Mark Pegram
HER-2 therapy. HER-2/neu diagnostics in breast cancer
HER-2/neu status of the primary breast cancer (PBC) is determined by immunohistochemistry and fluorescent in situ hybridization. Because of a variety of technical factors, however, the PBC may not accurately refl...